[1] 赵嘉咏,申晓靖,夏胜利,等.河南省哨点医院5岁以下儿童腹泻病例A组轮状病毒感染状况、临床特征及病原学研究[J].中华预防医学杂志,2017,51(1): 82-86.
[2] Troeger C, Khalil IA, Rao PC, et al.Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years[J]. JAMA Pediatrics, 2018, 172(10):958-965.
[3] Tate JE, Burton AH, Boschi-pinto C, et al. Global, regional, and national estimates of rotavirus mortality in children <5 years of age,2000-2013[J].Clin Infect Dis, 2016, 62(Suppl 2): s96-105.
[4] 沈思,赵根明.儿童轮状病毒感染的疾病负担与疫苗应用[J].中华儿科杂志, 2021, 59(5): 426-430.
[5] 陈燕飞,汪立先,王雷.2015—2017年湖北省口服轮状病毒减毒活疫苗安全性监测分析[J].现代预防医学, 2019, 46(2): 364-367.
[6] 范张洁,李锋,韩同武.郑州市2013—2018年疑似预防接种异常反应监测分析[J].华南预防医学,2020,46(5):526-529.
[7] Bravo L, Chitraka A, Liu A, et al.Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: A post-marketing surveillance study[J].Hum Vaccin Immunother,2014,10(8): 2276-283.
[8] 唐广心,陈娅妮,李苑,等.深圳市宝安区国产轮状病毒疫苗使用现况调查[J]. 国际病毒学杂志, 2020, 27(5): 417-420.
[9] 代秋菊,许红梅.轮状病毒疫苗保护效果及其影响因素研究进展[J].儿科药学杂志,2019,75(12):51-56.
[10] 张潮,张维溪,姜毅,等.温州市羔羊轮状病毒疫苗使用现况和安全性分析及1905例保护效果调查[J].现代预防医学, 2018, 45(12): 2258-2261.
[11] 刘娜. 我国轮状病毒的流行及免疫预防[J].中国实用儿科杂志,2021,36(5): 328-331.
[12] Kimberlin DW BM, Jackson MA.Red book: 2015 report of the committee on infectious diseases[M]. Itasca: American Academy of Pediatrics, 2015.
[13] Kacper T, Katarzyna J, Dawid L, et al.Rotavirus gastroenteritis in children hospitalized in northeastern Poland in 2006-2020: Severity, seasonal trends, and impact of immunization[J]. Int J Infect Dis, 2021, 108:550-556.
[14] Burnett E, Parashar UD, Tate JE.Real-world effectiveness of rotavirus vaccines, 2006-19: A literature review and meta-analysis[J].Lancet Glob Health,2020,8(9): e1195-1202.
[15] Thiem VD, Anh DD, Ha VH, et al.Safety and immunogenicity of two formulations of rotavirus vaccine in Vietnamese infants[J].Vaccine,2021,39(32): 4463-4470.
[16] 孟子延,张哲罡,张家友,等.单价和五价轮状病毒疫苗保护效果的Meta分析[J].国际病毒学杂志, 2018, 25(4): 224-227.
[17] 龚睿婕,刘景壹,陈远方,等.进口五价轮状病毒减毒活疫苗上市后疑似预防接种异常反应监测分析[J].预防医学论坛, 2021, 27(3): 169-171.
[18] Haber P, Tate J, Marquez PL, et al.Safety profile of rotavirus vaccines among individuals aged ≥ 8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019[J]. Vaccine, 2020, 39(4): 746-750.
[19] 陶育晖,王世申,胡芳芳.长春市2018—2019年婴幼儿口服轮状病毒减毒活疫苗不良反应分析[J].中国生物制品学杂志, 2020, 33(4): 429-433. |
